Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1990 May;58(5):1396–1401. doi: 10.1128/iai.58.5.1396-1401.1990

Specific labeling of cysteine proteinases in pathogenic and nonpathogenic Entamoeba histolytica.

F de Meester 1, E Shaw 1, H Scholze 1, T Stolarsky 1, D Mirelman 1
PMCID: PMC258638  PMID: 2323821

Abstract

Growth of Entamoeba histolytica trophozoites was inhibited by 50% at low concentrations (2.0 micrograms/ml) of the diazopeptidyl inhibitor benzyloxycarbonyl-leucyl-L-tyrosyldiazomethane (Z-L-Leu-L-Tyr-CHN2). Iodination of the tyrosine residue lowered the growth inhibitory efficacy of the diazopeptidyl inhibitor (50% inhibition, approximately 10 micrograms/ml). However, even at this concentration, practically all of the cysteine proteinase activity of the cells was irreversibly inactivated as shown by fluorescence microscopy with the dipeptide substrate L-Arg-L-Arg-4-methoxy-beta-napthylamide or colorimetrically with azocasein as the substrate. Growth of trophozoites of E. histolytica from various strains, including both pathogenic and nonpathogenic zymodemes, was similarly inhibited. The concentration of inhibitor required to inactivate the proteinase activity of nonpathogenic cells was lower. Lysates from trophozoites grown in the presence of sublethal concentrations of 125I-labeled protease inhibitor (10 micrograms/ml) showed as many as eight radioactive bands by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (molecular sizes, 73, 68, 56, 40, 39, 35, 29, and 27 kilodaltons). Two of these bands (molecular sizes, 29 and 27 kilodaltons) could be seen in gels of the cytoplasmic fraction, whereas the high-molecular-size bands were mostly associated with the membrane fraction. The radioactive bands in pathogenic and nonpathogenic strains were very similar with only minor differences. The results obtained show that E. histolytica cells, irrespective of their pathogenicity, possess a number of cysteine proteinases of similar molecular sizes which are vital for cell growth.

Full text

PDF
1399

Images in this article

1398Image
on p.1398
1399Image
on p.1399
1399Image
on p.1399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aley S. B., Scott W. A., Cohn Z. A. Plasma membrane of Entamoeba histolytica. J Exp Med. 1980 Aug 1;152(2):391–404. doi: 10.1084/jem.152.2.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bracha R., Chayen A., Rosenberg I., Warren L. G., Mirelman D. Isolation and partial characterization of the hexokinase isoenzymes from pathogenic and non-pathogenic strains of Entamoeba histolytica. Mol Biochem Parasitol. 1987 Sep;25(2):203–212. doi: 10.1016/0166-6851(87)90009-0. [DOI] [PubMed] [Google Scholar]
  3. Burchard G. D., Mirelman D. Entamoeba histolytica: virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes. Exp Parasitol. 1988 Aug;66(2):231–242. doi: 10.1016/0014-4894(88)90095-1. [DOI] [PubMed] [Google Scholar]
  4. Cedeño J. R., Krogstad D. J. Susceptibility testing of Entamoeba histolytica. J Infect Dis. 1983 Dec;148(6):1090–1095. doi: 10.1093/infdis/148.6.1090. [DOI] [PubMed] [Google Scholar]
  5. Crawford C., Mason R. W., Wikstrom P., Shaw E. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B. Biochem J. 1988 Aug 1;253(3):751–758. doi: 10.1042/bj2530751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Diamond L. S., Harlow D. R., Cunnick C. C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431–432. doi: 10.1016/0035-9203(78)90144-x. [DOI] [PubMed] [Google Scholar]
  7. Gadasi H., Kobiler D. Entamoeba histolytica: correlation between virulence and content of proteolytic enzymes. Exp Parasitol. 1983 Feb;55(1):105–110. doi: 10.1016/0014-4894(83)90003-6. [DOI] [PubMed] [Google Scholar]
  8. Gitler C., Mirelman D. Factors contributing to the pathogenic behavior of Entamoeba histolytica. Annu Rev Microbiol. 1986;40:237–261. doi: 10.1146/annurev.mi.40.100186.001321. [DOI] [PubMed] [Google Scholar]
  9. Green G. D., Shaw E. Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. J Biol Chem. 1981 Feb 25;256(4):1923–1928. [PubMed] [Google Scholar]
  10. Keene W. E., Petitt M. G., Allen S., McKerrow J. H. The major neutral proteinase of Entamoeba histolytica. J Exp Med. 1986 Mar 1;163(3):536–549. doi: 10.1084/jem.163.3.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kirschke H., Wikstrom P., Shaw E. Active center differences between cathepsins L and B: the S1 binding region. FEBS Lett. 1988 Feb 8;228(1):128–130. doi: 10.1016/0014-5793(88)80600-8. [DOI] [PubMed] [Google Scholar]
  12. Luaces A. L., Barrett A. J. Affinity purification and biochemical characterization of histolysin, the major cysteine proteinase of Entamoeba histolytica. Biochem J. 1988 Mar 15;250(3):903–909. doi: 10.1042/bj2500903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lushbaugh W. B., Hofbauer A. F., Pittman F. E. Entamoeba histolytica: purification of cathepsin B. Exp Parasitol. 1985 Jun;59(3):328–336. doi: 10.1016/0014-4894(85)90088-8. [DOI] [PubMed] [Google Scholar]
  14. Lushbaugh W. B., Hofbauer A. F., Pittman F. E. Proteinase activities of Entamoeba histolytica cytotoxin. Gastroenterology. 1984 Jul;87(1):17–27. [PubMed] [Google Scholar]
  15. Markwell M. A. A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum. Anal Biochem. 1982 Sep 15;125(2):427–432. doi: 10.1016/0003-2697(82)90025-2. [DOI] [PubMed] [Google Scholar]
  16. Mason R. W., Wilcox D., Wikstrom P., Shaw E. N. The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor. Biochem J. 1989 Jan 1;257(1):125–129. doi: 10.1042/bj2570125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mirelman D., Bracha R., Wexler A., Chayen A. Changes in isoenzyme patterns of a cloned culture of nonpathogenic Entamoeba histolytica during axenization. Infect Immun. 1986 Dec;54(3):827–832. doi: 10.1128/iai.54.3.827-832.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mirelman D., De Meester F., Stolarsky T., Burchard G. D., Ernst-Cabrera K., Wilchek M. Effects of covalently bound silica-nitroimidazole drug particles on Entamoeba histolytica. J Infect Dis. 1989 Feb;159(2):303–309. doi: 10.1093/infdis/159.2.303. [DOI] [PubMed] [Google Scholar]
  19. Mirelman D., Monheit D., Varon S. Inhibition of growth of Entamoeba histolytica by allicin, the active principle of garlic extract (Allium sativum). J Infect Dis. 1987 Jul;156(1):243–244. doi: 10.1093/infdis/156.1.243. [DOI] [PubMed] [Google Scholar]
  20. Ostoa-Saloma P., Cabrera N., Becker I., Perez-Montfort R. Proteinases of Entamoeba histolytica associated with different subcellular fractions. Mol Biochem Parasitol. 1989 Jan 15;32(2-3):133–143. doi: 10.1016/0166-6851(89)90064-9. [DOI] [PubMed] [Google Scholar]
  21. Perez-Montfort R., Ostoa-Saloma P., Velazquez-Medina L., Montfort I., Becker I. Catalytic classes of proteinases of Entamoeba histolytica. Mol Biochem Parasitol. 1987 Nov;26(1-2):87–97. doi: 10.1016/0166-6851(87)90133-2. [DOI] [PubMed] [Google Scholar]
  22. Reilly J. J., Jr, Mason R. W., Chen P., Joseph L. J., Sukhatme V. P., Yee R., Chapman H. A., Jr Synthesis and processing of cathepsin L, an elastase, by human alveolar macrophages. Biochem J. 1989 Jan 15;257(2):493–498. doi: 10.1042/bj2570493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sargeaunt P. G., Williams J. E. Electrophoretic isoenzyme patterns of Entamoeba histolytica and Entamoeba coli. Trans R Soc Trop Med Hyg. 1978;72(2):164–166. doi: 10.1016/0035-9203(78)90053-6. [DOI] [PubMed] [Google Scholar]
  24. Scholze H., Werries E. A weakly acidic protease has a powerful proteolytic activity in Entamoeba histolytica. Mol Biochem Parasitol. 1984 Apr;11:293–300. doi: 10.1016/0166-6851(84)90073-2. [DOI] [PubMed] [Google Scholar]
  25. Scholze H., Werries E. Cysteine proteinase of Entamoeba histolytica. I. Partial purification and action on different enzymes. Mol Biochem Parasitol. 1986 Jan;18(1):103–112. doi: 10.1016/0166-6851(86)90054-x. [DOI] [PubMed] [Google Scholar]
  26. Schulte W., Scholze H., Werries E. Specificity of a cysteine proteinase of Entamoeba histolytica towards the alpha 1-CB2 peptide of bovine collagen type I. Mol Biochem Parasitol. 1987 Aug;25(1):39–43. doi: 10.1016/0166-6851(87)90016-8. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES